Purchases and Sales Made in Q1 2023 in Virpax Pharmaceuticals, Inc. (VRPX)
This table provides information about the institutional ownership of Virpax Pharmaceuticals, Inc. (VRPX) during Q1 2023. The information is specifically focused on institutions that hold shares of Virpax Pharmaceuticals, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 09, 2023
Q1 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
333+ 6.49% |
$223 - $383
|
5.46K
$2.29K
|
|
|
May 12, 2023
Q1 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 1.69% |
$0.67 - $1.15
|
60
$25.2
|
|
|
May 15, 2023
Q1 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
May 11, 2023
Q1 2023
|
Cambridge Investment Research Advisors, Inc.
|
SELL
|
- |
-400- 2.43% |
$268 - $460
|
16.1K
$6.75K
|
|
|
May 12, 2023
Q1 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
SELL
|
- |
-900- 0.94% |
$603 - $1.04K
|
95.3K
$40K
|
|
|
May 15, 2023
Q1 2023
|
Morgan Stanley
New York, NY |
SELL
|
- |
-926- 86.06% |
$620 - $1.06K
|
150
$63
|
|
|
May 15, 2023
Q1 2023
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-113K- 63.35% |
$75.4K - $129K
|
65.1K
$27.4K
|
|
|
May 15, 2023
Q1 2023
|
Sabby Management, LLC
Upper Saddle River, NJ |
SELL
|
- |
-287K- 29.01% |
$192K - $330K
|
701K
$295K
|